A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics.
Clinical trial NCT03740555 · COMPLETED
Trial details
- NCT number
- NCT03740555
- Sponsor
- Guangzhou Henovcom Bioscience Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2019-07-19
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.